Meet Creoptix at the 8th RSC-BMCS Fragment-based Drug Discovery in-person event in Cambridge (UK) to discuss molecular interaction analysis with focus on the Grating-Coupled Interferometry (GCI) technology.
About the event
The aim of the 8th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with this theme in having over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high concentration, NMR, SPR and X-ray screening.
Churchill College, Cambridge, UK plus Virtual
Who should attend?
This conference is suitable for scientists including chemists, biophysicists, structural biologists, etc., with either existing experience of fragments or wanting to learn about this exciting approach to drug discovery.